Hypertension is a major risk factor for the development of stroke. It is well known that lowering blood pressure decreases the risk of stroke in people with moderate to severe hypertension. However, the specific effects of calcium channel blockers (CCBs) against stroke in patients with hypertension as compared to no treatment and other antihypertensive drug classes are not known.), statistically significant difference was not found between CCBs and ACEIs (OR = 0.92, 95% CI 0.8–1.02, p = 0.12) or diuretics (OR = 0.95, 95% CI 0.84–1.07, p = 0.39).In a pooled analysis of data of 31 RCTs measuring the effect of CCBs on stroke, CCBs reduced stroke more than placebo and β-adrenergic blockers, but were not different than ACEIs and diuretics. More ...
We investigated whether protection from coronary heart disease (CHD) and stroke conferred by angiote...
The authors aimed to investigate the superiority of angiotensin system blockade (angiotensin-convert...
The authors aimed to investigate the superiority of angiotensin system blockade (angiotensin-convert...
BACKGROUND: Hypertension is a major risk factor for the development of stroke. It is well known that...
Background: Hypertension is a major risk factor for the development of stroke. It is well known that...
BACKGROUND: The possibility that specific antihypertensive treatments may prevent the occurrence of ...
BACKGROUND: The possibility that specific antihypertensive treatments may prevent the occurrence of ...
OBJECTIVES We present a meta-analysis based on three recent, substantial, randomized outcome trials ...
This review evaluates the current position of calcium channel blockers (CCB) in antihypertensive tre...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
AbstractObjectivesWe present a meta-analysis based on three recent, substantial, randomized outcome ...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
The present review aims to analyze the role of calcium-channel blockers, and particularly newer mole...
We investigated whether protection from coronary heart disease (CHD) and stroke conferred by angiote...
The authors aimed to investigate the superiority of angiotensin system blockade (angiotensin-convert...
The authors aimed to investigate the superiority of angiotensin system blockade (angiotensin-convert...
BACKGROUND: Hypertension is a major risk factor for the development of stroke. It is well known that...
Background: Hypertension is a major risk factor for the development of stroke. It is well known that...
BACKGROUND: The possibility that specific antihypertensive treatments may prevent the occurrence of ...
BACKGROUND: The possibility that specific antihypertensive treatments may prevent the occurrence of ...
OBJECTIVES We present a meta-analysis based on three recent, substantial, randomized outcome trials ...
This review evaluates the current position of calcium channel blockers (CCB) in antihypertensive tre...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
AbstractObjectivesWe present a meta-analysis based on three recent, substantial, randomized outcome ...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
The present review aims to analyze the role of calcium-channel blockers, and particularly newer mole...
We investigated whether protection from coronary heart disease (CHD) and stroke conferred by angiote...
The authors aimed to investigate the superiority of angiotensin system blockade (angiotensin-convert...
The authors aimed to investigate the superiority of angiotensin system blockade (angiotensin-convert...